Sino Medical Sciences Technology In Cash Flow Quality Index
Sino Medical Sciences Technology In cash flow quality index. Sino Medical Sciences Technology In (688108) has a Cash Flow Quality Index of 4.33x as of September 2025. Operating cash flow of CN¥31.52 Million exceeds net income of CN¥7.28 Million, indicating high earnings quality where cash backs reported profits. See Sino Medical Sciences Technology In free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Sino Medical Sciences Technology In (2016–2025)
Cash flow quality index of Sino Medical Sciences Technology In from 2016 to 2025. Historical Cash Flow Quality Index for Sino Medical Sciences Technology In across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Sino Medical Sciences Technology In cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Sino Medical Sciences Technology In Cash Flow Quality Index by Year (2016–2025)
Sino Medical Sciences Technology In cash flow quality index by year from 2016 to 2025. Year-by-year earnings quality comparison for Sino Medical Sciences Technology In. For the full cash flow conversion analysis, see Sino Medical Sciences Technology In operating cash flow efficiency.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 3.42x | CN¥161.87 Million | CN¥47.29 Million | ▲ +9.2% |
| 2020 | 3.13x | CN¥70.51 Million | CN¥22.49 Million | ▲ +105.1% |
| 2019 | 1.53x | CN¥137.61 Million | CN¥90.04 Million | ▲ +39.7% |
| 2018 | 1.09x | CN¥97.56 Million | CN¥89.19 Million | ▲ +2.9% |
| 2017 | 1.06x | CN¥70.32 Million | CN¥66.15 Million | ▼ -27.9% |
| 2016 | 1.47x | CN¥42.24 Million | CN¥28.65 Million | — |